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OBJECTIVE — We examined prevalence of sarcopenia in Korean patients with type 2 dia-
betes and compared body compositional parameters between subjects with and without type 2
diabetes.
RESEARCH DESIGN AND METHODS — The Korean Sarcopenic Obesity Study
(KSOS) included 810 subjects (414 patients with diabetes and 396 control subjects) who were
examined using dual-energy X-ray absorptiometry. Prevalence of sarcopenia was deﬁned using
the skeletal muscle index (SMI).
RESULTS — Prevalenceinpatientswithdiabetesandinthecontrolgroupwas15.7and6.9%,
respectively. In both men and women, SMI values were signiﬁcantly decreased in patients with
diabetes compared with subjects without diabetes. Furthermore, multiple logistic regression
analysis showed that type 2 diabetes was independently associated with sarcopenia.
CONCLUSIONS — Type 2 diabetes was associated with increased risk of sarcopenia. These
characteristicsmaycontributetophysicaldisabilityandmetabolicdisordersinolderadultswith
diabetes.
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P
eople in Asia tend to develop type 2
diabetes with less degree of obesity
(1). In addition, Asian populations
are more prone to abdominal obesity
and low skeletal muscle mass (sarcope-
nia) with increased insulin resistance
compared with their Western counter-
parts (2).
Type 2 diabetes is associated with
lowerskeletalmusclestrengthandquality
as well as excessive loss of skeletal muscle
mass in the Health, Aging, and Body
Composition (Health ABC) study (3,4).
Recently, we examined prevalence of sar-
copeniainnondiabeticKoreanadultsand
found that sarcopenic obesity deﬁned us-
ing the skeletal muscle index (SMI (%):
total skeletal muscle mass (kg)/weight
(kg)  100) was associated with in-
creased risk of metabolic syndrome (5).
The aim of the current study was to
examine prevalence of sarcopenia in Ko-
rean patients with type 2 diabetes and to
compare body compositional parameters
between subjects with and without
diabetes.
RESEARCH DESIGN AND
METHODS— The Korean Sarcopenic
Obesity Study (KSOS) enrolled 446 well-
functioning community-dwelling healthy
volunteers without diabetes recruited
from residents of Seoul, Korea, and 428
diabetic patients treated at the Diabetes
Center of Korea University Guro Hospi-
tal. Analysis was conducted on 810 sub-
jects (414 patients with type 2 diabetes
and 396 control subjects) who were ex-
amined using dual-energy X-ray absorp-
tiometry (Hologic Discovery A; Hologic,
Bedford, MA). Medical histories and
lifestyle information were collected by
personal interview using a detailed ques-
tionnaire (6). The Korea University Insti-
tutional Review Board approved this
study protocol.
Appendicular skeletal muscle mass
(ASM), ASM/height
2, and SMI were per-
formed as previously described (7–10).
SarcopeniawasdeﬁnedasSMI2SDbe-
low the mean of the young reference
group (see supplementary Table 2, avail-
able in an online appendix at http://
care.diabetesjournals.org/cgi/content/
full/dc09-2310/DC1). We previously es-
tablished cutoff values for sarcopenia
(5). Further information on study de-
sign and methods is given in the online
appendix.
RESULTS— Figure 1 presents the scat-
ter plots for the association between age
and ASM and SMI, according to sex and
diabetes status. Total lean body mass and
SMIinmenwithdiabeteswerelowerthan
in control subjects after adjustment for
covariates such as age, BMI, health-
related behaviors, medication, and meta-
bolic parameters. In women, ASM/
height
2 and SMI in patients with diabetes
were lower than in nondiabetic counter-
parts (supplementary Table 1).
Prevalence of sarcopenia in patients
with diabetes and in the control group
was 15.7 and 6.9%, respectively. In
subjects older than 60 years, prevalence
of sarcopenia was greater in both men
and women with diabetes than in non-
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P  0.005, in men and 27.0 vs. 14.0%,
P  0.013, in women). However, in the
middle-agedgroup(age40–59years),a
signiﬁcant difference in prevalence of
sarcopenia between groups with and
without diabetes was observed only in
women (16.7 vs. 4.1%, P  0.002)
(supplementary Table 3). Patients with
diabetes had three times higher risk of
sarcopenia (odds ratio 3.06, 95% CI
1.42–6.62) than subjects without dia-
betes after adjusting for age, sex, BMI,
smoking, alcohol drinking, physical ac-
tivity, medications, blood pressure, and
lipid proﬁles (supplementary Table 4).
CONCLUSIONS — In the present
study, we ﬁrst examined prevalence of
sarcopenia in patients with type 2 dia-
betes, and the present study showed
that men with diabetes had decreased
lean body mass and increased body fat
mass, even though they had similar BMI
compared with nondiabetic subjects.
Moreover, compared with nondiabetic
counterparts, both men and women
withdiabeteshaddecreasedSMIvalues.
However,inacross-sectionalanalysisof
the Health ABC study that included
Western elderly subjects, patients with
type 2 diabetes exhibited increases in
both lean body mass and body fat mass
compared with subjects without diabe-
tes, because, compared with nondia-
betic subjects, those with diabetes were
more obese and had higher BMI (3). Al-
ternatively, this study reported that in-
dividuals with diabetes had either
weaker (men) or not stronger (women)
muscle strength than individuals with-
outdiabetesdespitelargermusclemass.
This difference of sarcopenia between
Asian patients and Western patients
with type 2 diabetes might originate
from ethnic differences in characteris-
tics of type 2 diabetes.
Interestingly, middle-aged women as
well as elderly women with diabetes ex-
hibited higher prevalence of sarcopenia
thanindividualswithoutdiabetes,despite
this difference not being signiﬁcant in
middle-aged men. Our ﬁndings are in
agreement with several previous studies
demonstrating that men lose greater skel-
etal muscle mass with aging, even though
they have greater skeletal muscle mass
than women (11,12) and that women
with diabetes are at particularly high risk
for loss of skeletal muscle mass (4). These
results imply that type 2 diabetes is an
importantpredictorofsarcopenia,partic-
ularly in women, and that this relation-
ship in men is mainly restricted to elderly
people.
A limitation of this study was that our
study was performed using baseline data
from an ongoing prospective cohort
study. Therefore, it is not possible to im-
pute causality. However, we are perform-
ing a follow-up survey to explore the
longitudinal interrelationship between
diabetes and sarcopenia in Korean adults.
In conclusion, the present study
showed that prevalence of sarcopenia
was higher in Korean patients with
type 2 diabetes, particularly in women
and the elderly. Furthermore, type 2 di-
abetes was independently associated
with increased risk of sarcopenia after
adjusting for potential risk factors.
These results suggest that patients with
type 2 diabetes are at risk of developing
sarcopenia.
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